The HER2/neu oncogene, a transmembrane tyrosine kinase receptor belonging to the epidermal growth factorreceptor (EGFR) family, has been shown to be amplified in up to 30% of human breast cancer cell lines (Slamon etal., 1987). The gene discussed is EGFR; the disease is breast carcinoma.